Amylyx Pharmaceuticals, Inc. had the highest capex growth among pharmaceutical and biotech companies worldwide in 2024, with a growth rate of over percent. Capital expenditures are defined as funds used by a company to acquire or upgrade physical assets, such as property, industrial buildings, or equipment.
U.S. pharmaceutical and biotech industry
Several of the pharmaceutical and biotech companies with high capex growth rates are based in the United States, for example, Cara Therapeutics, Prokidney, and Kymera Therapeutics. In 2024, the country accounted for over ** percent of the global pharmaceutical market. China, which has a much larger population than the United States, had a roughly percent market share. In the same year, the United States had a nominal spending on medicine of over *** billion U.S. dollars. This was more than double the amount spent back in 2013.Â
In 2025, the largest American pharmaceutical company based on revenue was Johnson & Johnson. The multinational biopharmaceutical company is headquartered in New Jersey and annually generates more than ** billion U.S. dollars’ worth of annual revenue.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
European Commission, & Joint Research Centre. (December 22, 2025). Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by capital expenditure growth [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 31, 2026, from /statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission, und Joint Research Centre. "Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by capital expenditure growth ." Chart. December 22, 2025. ÌÇÐÄÆÆ½â°æ. Accessed July 31, 2026. /statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission, Joint Research Centre. (2025). Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by capital expenditure growth . ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 31, 2026. /statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission, and Joint Research Centre. "Leading 50 Pharmaceutical and Biotechnology Companies Worldwide in 2024, by Capital Expenditure Growth ." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 22 Dec 2025, /statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission & Joint Research Centre, Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by capital expenditure growth ÌÇÐÄÆÆ½â°æ, /statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/ (last visited July 31, 2026)
Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by capital expenditure growth [Graph], European Commission, & Joint Research Centre, December 22, 2025. [Online]. Available: /statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/